HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration (HiPED)

This study has been terminated.
(Drug dose became unavailable)
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Anne Fung MD, Pacific Eye Associates
ClinicalTrials.gov Identifier:
NCT01189019
First received: August 24, 2010
Last updated: March 28, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)